Shares of Aeterna Zentaris (NASDAQ:AEZS) were the recipient of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 3,148,542 shares, an increase of 44.8% from the January 15th total of 2,174,377 shares, Analyst Ratings.Net reports. Based on an average trading volume of 1,781,422 shares, the short-interest ratio is presently 1.8 days. Currently, 5.8% of the shares of the company are sold short. AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) stock opened at $1.43 in last session, and closed at $1.38, while the day range of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) stock is $1.32 – $1.44. The stock showed a positive weekly performance of 7.81%.
La Jolla Pharmaceutical Company (NASDAQ:LJPC) said its lead experimental drug to treat chronic kidney disease met the main goal of improving kidney function in a mid-stage study, sending the company’s shares up about 40 percent in extended trading. La Jolla Pharmaceutical Company (NASDAQ:LJPC) stock opened at $17.25 in last session, and closed at $15.82 by losing -11.92%. The 52 week range of $2.75 – $19.50. Company’s market capitalization is $8.70 million.
Prana Biotechnology Limited (NASDAQ:PRAN) is development Stage Company. The Company is engaged in develop therapeutic drugs designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses, initially focusing on Alzheimer’s disease. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) stock decreased -5.50% and finished the last session at $9.45. The EPS of the stock remained -0.27. Company’s market capitalization is $380.87 million.
Cytori Therapeutics (NASDAQ:CYTX) issued its quarterly earnings data on Tuesday. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by $0.02, AnalystRatingsNetwork.com reports. The company had revenue of $2.71 million for the quarter, compared to the consensus estimate of $4.37 million. Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) stock opened the session at $3.07, and closed the session at $2.89. The 52 week range of the Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) stock remained $2.00 – $3.93 and the day range was $2.81 – $3.07.
Leave a Reply